These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29733853)

  • 21. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK.
    Wolf ER; McAtarsney CP; Bredhold KE; Kline AM; Mayo LD
    Sci Signal; 2018 Apr; 11(524):. PubMed ID: 29615516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Backbone resonance assignments of the human p73 DNA binding domain.
    Cino EA; Soares IN; Freitas MS; Silva JL
    Biomol NMR Assign; 2016 Apr; 10(1):49-51. PubMed ID: 26294377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.
    Humbert M; Federzoni EA; Tschan MP
    J Leukoc Biol; 2017 Dec; 102(6):1357-1370. PubMed ID: 28978663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin-β4 is a novel transcriptional target of TAp73.
    Xie N; Vikhreva P; Annicchiarico-Petruzzelli M; Amelio I; Barlev N; Knight RA; Melino G
    Cell Cycle; 2018; 17(5):589-594. PubMed ID: 29233040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
    Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
    J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Gomez LC; Sottile ML; Guerrero-Gimenez ME; Zoppino FCM; Redondo AL; Gago FE; Orozco JI; Tello OM; Roqué M; Nadin SB; Marzese DM; Vargas-Roig LM
    J Clin Pathol; 2018 Jan; 71(1):52-58. PubMed ID: 28743687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
    Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
    Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The armadillo-repeat domain of plakophilin 1 binds the C-terminal sterile alpha motif (SAM) of p73.
    Neira JL; Rizzuti B; Ortega-Alarcón D; Giudici AM; Abián O; Fárez-Vidal ME; Velázquez-Campoy A
    Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129914. PubMed ID: 33872756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAp73 and ΔNp73 relative expression in Egyptian patients with lymphoid neoplasms.
    Hamdy MSA; El-Saadany ZA; Makhlouf MM; Salama AI; Ibrahim NS; Gad AA
    Tumori; 2017 May; 103(3):268-271. PubMed ID: 27103208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors.
    Omran Z; H Dalhat M; Abdullah O; Kaleem M; Hosawi S; A Al-Abbasi F; Wu W; Choudhry H; Alhosin M
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond.
    Logotheti S; Richter C; Murr N; Spitschak A; Marquardt S; Pützer BM
    Front Cell Dev Biol; 2021; 9():737735. PubMed ID: 34650986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy.
    Naseer F; Saleem M
    Oncol Rev; 2019 Jul; 13(2):421. PubMed ID: 31410249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.